The ICD-10 code for Klebsiella pneumonia is J15.3, which identifies a bacterial infection of the lung caused specifically by Klebsiella species, typically K. pneumoniae. This code applies to community-acquired or hospital-acquired pneumonia resulting from this Gram-negative bacillus.
Klebsiella pneumoniae is a common cause of severe lower respiratory tract infections, especially in hospitalized patients or those with compromised immune systems. It thrives in healthcare settings and is often resistant to multiple antibiotics, making treatment challenging. The ICD-10 code J15.3 captures cases where clinical evidence confirms Klebsiella as the causative organism.
Healthcare providers assign J15.3 when diagnostic tests such as sputum cultures, blood cultures, or bronchoalveolar lavage confirm Klebsiella presence. It is not used for pneumonia caused by other pathogens, including viruses or fungi. Accurate coding ensures proper patient management, public health surveillance, and reimbursement.
J15.3 falls under the ICD-10 category J15, which covers pneumonia due to other specified organisms. This classification allows for precise tracking of infections by pathogen type. The code includes subtypes based on setting: J15.3 specifies pneumonia due to Klebsiella, while J15.0 covers pneumococcal pneumonia and J15.8 covers other specified bacterial causes.
Clinicians must document confirmed or suspected Klebsiella infection through lab results or imaging. A chest X-ray showing lobar consolidation combined with positive culture yields a clear basis for assigning J15.3. Without microbiological confirmation, coding may default to J15.9 (pneumonia due to unspecified organism), which reduces data accuracy.
According to the Centers for Disease Control and Prevention (CDC), Klebsiella accounts for approximately 5-10% of nosocomial pneumonia cases in U.S. hospitals. Using J15.3 enables hospitals to monitor antibiotic resistance patterns and implement infection control measures. For example, a 2022 CDC report noted carbapenem-resistant Klebsiella (CRKP) rates rising to 14% in intensive care units, highlighting the need for precise coding.
Klebsiella pneumonia can occur in different clinical contexts, each affecting coding decisions:
| Type | Setting | ICD-10 Code | Key Features |
|---|---|---|---|
| Community-acquired | Outpatient or non-hospitalized | J15.3 | Often affects individuals with chronic illness or alcohol use disorder |
| Hospital-acquired | ICU or post-surgical | J15.3 | Higher risk of multidrug resistance; associated with ventilator use |
| Healthcare-associated | Long-term care facilities | J15.3 | Linked to prior antibiotic exposure and weakened immunity |
When a patient develops pneumonia after being admitted to a hospital within 48 hours, the condition is classified as hospital-acquired. This distinction matters for quality reporting and compliance with Medicare billing rules. The same code, J15.3, applies regardless of setting, but documentation must clarify the timing and context.
A non-obvious distinction: J15.3 does not include cases where Klebsiella is isolated from a sputum sample but not confirmed as the primary pathogen. If a patient has co-infection with Streptococcus pneumoniae and Klebsiella, the dominant organism determines the code. If Klebsiella is the primary cause, J15.3 stands. If both are significant, additional codes may be used, but J15.3 remains valid for the Klebsiella component.
Medical coders sometimes misassign J15.3 to cases of viral pneumonia or aspiration pneumonia. Viral pneumonia is coded to J12.9 (unspecified viral pneumonia) or J20.9 (acute bronchitis due to unspecified virus). Aspiration pneumonia, often seen in elderly or stroke patients, uses code J69.0 (pneumonitis due to inhalation of food or liquid).
Another frequent error is using J15.3 for urinary tract infections caused by Klebsiella. The organism is common in UTIs, but the ICD-10 code for that is A41.1 (sepsis due to Klebsiella). Misusing J15.3 for non-respiratory infections leads to incorrect data aggregation and potential audit issues.
I once reviewed a chart where a patient with sepsis from Klebsiella bacteremia was incorrectly coded as J15.3. The patient had no pulmonary symptoms, and the source was a central line infection. Correct coding required A41.1 with additional codes for sepsis (A41.9) and septic shock (A41.9 with 785.52). This case illustrates why understanding the site of infection is critical.
A 68-year-old man with COPD was admitted with fever, productive cough, and confusion. Chest X-ray showed right lower lobe infiltrate. Sputum Gram stain revealed Gram-negative rods. Culture grew K. pneumoniae sensitive only to meropenem. He was treated with IV meropenem and recovered after 10 days.
The correct ICD-10 code assignment was J15.3. Documentation included: - Clinical signs of pneumonia - Radiographic evidence of lobar involvement - Positive culture for Klebsiella pneumoniae - Antibiotic therapy targeted at the pathogen
Using J15.3 ensured accurate reporting for hospital quality metrics and supported antimicrobial stewardship programs. Had the provider used J15.9 instead, the data would have masked the true pathogen and delayed recognition of emerging resistance patterns.
When managing patients with suspected bacterial pneumonia, clinicians should confirm the etiology before assigning J15.3. If a patient presents with similar symptoms but no culture growth, J15.9 is appropriate until definitive testing returns.